BioSpace News Archive

CardieX Limited, a global health technology company focused on cardiovascular disease, announced that it has acquired all the assets of Blumio, Inc., a Silicon Valley based developer of advanced algorithms and technology for cardiovascular sensors, signifying the company’s continued investment in cardiovascular health monitoring technologies.

NeuroQuest, a company focused on the discovery of blood-based immune biomarkers in pre-clinical stage Alzheimer’s, announced that together with the Australian Imaging, Biomarker & Lifestyle Flagship Study (AIBL), it has completed a clinical study demonstrating that specific immune deficits that are associated with the development of Alzheimer’s disease may be identified.

Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, announced that Daniel De Carvalho, PhD will deliver a plenary session titled “Cancer Early Detection, Classification and Monitoring using Plasma Cell-Free DNA Methylomes” at the AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer on November 18, 2022.

Garuda Therapeutics, a company creating off-the-shelf, durable blood stem cell therapies, announced the appointment of David DiGiusto, Ph.D., as Chief Technology Officer.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2023 on Tuesday, November 22, 2022.

Rockley Photonics Holdings Limited, a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, announced that it will participate in the following investor conferences.

Riverain Technologies, the pioneer of Clear Visual Intelligence™ for chest imaging interpretation, was selected by the Veterans Health Administration to provide its unique imaging interpretation solution, ClearRead™ CT, to the Veteran Affair’s Lung Precision Oncology Program.

Pharmaceutics International, Inc., a contract development and manufacturing organization has been promoted Devan Patel to Vice President – Client Services, where he will oversee Pii’s Business Operations & Program Management functions.

Cytek Biosciences, Inc. announced the launch of Cytek Cloud – a cloud-based platform that features two integrated tools to streamline workflows on Cytek’s state-of-the-art cell sorters and analyzers.

Intelivation Technologies, a medical device company with a cutting-edge orthopedic portfolio announced today the launch of the Inlet Foot Plating System™.